Philippines Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Philippines Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The Philippines Clinical Nutrition for Diabetes Care Market was valued at $4.73 Mn in 2023 and is predicted to grow at a CAGR of 5.28% from 2023 to 2030, to $6.78 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are United Laboratories, Inc. (Unilab), Zuellig Pharma, Sanofi, and Novo Nordisk among others.

ID: IN10PHPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: Phillipines AUTHOR: Avantika Gupta

Buy Now

Philippines Clinical Nutrition for Diabetes Care Market Executive Summary

The Philippines Clinical Nutrition for Diabetes Care Market is at around $4.73 Mn in 2023 and is projected to reach $6.78 Mn in 2030, exhibiting a CAGR of 5.28% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients control blood sugar, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and improve overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies include Zemaica Healthcare, Sanofi is known for its extensive portfolio of medications, including those essential for diabetes care. Zuellig Pharma, Nestlé Health Science, and Novo Nordisk are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

Philippines Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Expansion of Healthcare Infrastructure: The Philippines is working to improve its healthcare infrastructure and coverage through initiatives like the Universal Health Care Act. It aims to provide all Filipinos with equitable access to high-quality health services, including those related to diabetes care. This will enable more people with diabetes to access specialized clinical nutrition services as part of their comprehensive diabetes management.

Increasing Prevalence of Diabetes: Diabetes has progressively increased globally in recent decades, owing to causes such as sedentary lifestyles, bad food habits, and rising obesity rates. The Philippines has a significant diabetic population, As per the International Diabetes Federation, about 7.5% of adults have diabetes. There is growing demand for effective nutrition interventions to manage blood sugar levels and prevent complications, driving market growth

Limited Access to Diabetes Care: Many Filipinos with diabetes face challenges in accessing proper diabetes management and care due to insufficient healthcare financing, fragmented referral systems, and high out-of-pocket costs. This creates demand for clinical nutrition products and services.

Market Restraints

High Cost of Specialized Products: Specialized diabetic nutrition products can be expensive compared to regular food options. This can be a major barrier for low-income families and those in remote areas with limited healthcare resources This highlights the financial burden associated with the high cost of specialized therapeutic foods used to treat diabetes.

Lack of Access to Registered Dietitians: There is a shortage of registered dietitians or healthcare professionals trained in clinical nutrition for diabetes. This can limit access to proper consultations and personalized plans, hindering the effectiveness of these interventions.

Cultural Preferences: Traditional Filipino cuisine often relies heavily on white rice and refined carbohydrates. This can make it challenging for some patients to adopt a diabetic diet that aligns with their cultural food preferences

Regulatory Landscape and Reimbursement Scenario

The Philippine Food and Drug Administration (FDA) likely plays a role in regulating the manufacturing, marketing, and labeling of any specialized diabetic nutritional products. They would ensure the safety and proper labeling of ingredients and claims. The Philippine Association of Nutritionists and Dietitians (PANAD) has its code of ethics and practice standards that its members must follow when providing clinical nutrition services for diabetes management.
The National Health Insurance Program (PhilHealth), does not cover comprehensive diabetes care, including clinical nutrition services. Due to the lack of comprehensive insurance coverage, most diabetes patients in the Philippines have to pay high out-of-pocket expenses for clinical nutrition services and other diabetes care. The fragmented healthcare system and limited access to specialized diabetes care in the Philippines make it difficult for patients to consistently receive clinical nutrition services as part of their diabetes management

Competitive Landscape

Key Players

Here are some of the major key players in the Philippines Clinical Nutrition for Diabetes Care Market:

Abbott Nutrition
United Laboratories, Inc. (Unilab)
Fresenius Kabi
Nestlé S.A.
Zemaica Healthcare
Best Source Nutrition Pvt. Ltd.
Sanofi
Pascual Laboratories, Inc.
Zuellig Pharma
Novo Nordisk

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Philippines Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.